Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women

Detalhes bibliográficos
Autor(a) principal: Torres, Thiago S.
Data de Publicação: 2018
Outros Autores: Harrison, Linda J., La Rosa, Alberto M., Cardoso, Sandra W., Zheng, Lu, Ngongondo, McNeil, Some, Fatma F., Lalloo, Umesh G., Mwelase, Thando, Collier, Ann C., Hughes, Michael D.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/57161
Resumo: Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
id CRUZ_cb78b26590ff60631487d23ada91a030
oai_identifier_str oai:www.arca.fiocruz.br:icict/57161
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Torres, Thiago S.Harrison, Linda J.La Rosa, Alberto M.Cardoso, Sandra W.Zheng, LuNgongondo, McNeilSome, Fatma F.Lalloo, Umesh G.Mwelase, ThandoCollier, Ann C.Hughes, Michael D.2023-03-01T02:39:28Z2023-03-01T02:39:28Z2018TORRES, Thiago S. et al. Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS, v. 32, n. 5, p. 583-593, 2018.0269-9370https://www.arca.fiocruz.br/handle/icict/5716110.1097/QAD.0000000000001738engWolters Kluwer Healthhttps://www.arca.fiocruz.br/handle/icict/28806Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and womeninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleCenter for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA.Asociación Civil Impacta Salud y Educación, Lima, Peru.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA.Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA / UNC Project Lilongwe, Malawi.AMPATH at Moi University Teaching Hospital, Eldoret, Kenya.Durban Adult HIV CRS, South Africa.Wits Health Consortium Department of Medicine, University of Witwatersrand, Johannesburg, South Africa.Department of Medicine, University of Washington, Seattle, WA, USA.Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA.Objective: We evaluated improvement of quality of life (QoL) after 1 year of second-line antiretroviral therapy (ART) use in resource-limited settings (RLS) among adult men and women, comparing two randomized treatment arms. Design: The AIDS Clinical Trial Group A5273 was a randomized clinical trial of second-line ART comparing lopinavir/ritonavir (LPV/r) + raltegravir with LPV/r + nucleos(t)ide reverse transcriptase inhibitors (NRTIs) in participants failing a non-NRTI-containing regimen at 15 sites in nine RLS. Participants completed the AIDS Clinical Trial Group short-form-21 which has eight QoL domains with a standard score ranging from 0 (worst) to 100 (best). Methods: Differences in QoL by randomized arm, as well as by demographic and clinical variables, were evaluated by regression models for baseline and week 48 QoL scores fitted using the generalized estimating equations method. Results: A total of 512 individuals (49% men, median age 39 years) were included. A total of 512 and 492 participants had QoL assessments at baseline and week 48, respectively. QoL improved significantly from baseline to week 48 (P < 0.001 for all domains). There was no significant difference between treatment arms for any domain. Individuals with higher viral load and lower CD4 cell count at baseline had lower mean QoL at baseline but larger improvements such that mean QoL was similar at week 48. Conclusion: Improvements in QoL were similar after starting second-line ART of LPV/r combined with either raltegravir or NRTIs in RLS. QoL scores at baseline were lower among participants with worse disease status prior to starting second-line, but after 1 year similar QoL scores were achieved.Quality of lifeRaltegravirHIVSecond-line therapyAntiretroviral TherapyResource-limited settingsRandomized clinical trialinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALve_Torres_Thiago_etal_INI_2018_ARTIGO FINAL.pdfve_Torres_Thiago_etal_INI_2018_ARTIGO FINAL.pdfapplication/pdf467382https://www.arca.fiocruz.br/bitstream/icict/57161/2/ve_Torres_Thiago_etal_INI_2018_ARTIGO%20FINAL.pdfb2e25459fdc195a8d3ce45704cdbc097MD52LICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/57161/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51icict/571612023-02-28 23:39:29.311oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-01T02:39:29Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
title Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
spellingShingle Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
Torres, Thiago S.
Quality of life
Raltegravir
HIV
Second-line therapy
Antiretroviral Therapy
Resource-limited settings
Randomized clinical trial
title_short Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
title_full Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
title_fullStr Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
title_full_unstemmed Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
title_sort Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
author Torres, Thiago S.
author_facet Torres, Thiago S.
Harrison, Linda J.
La Rosa, Alberto M.
Cardoso, Sandra W.
Zheng, Lu
Ngongondo, McNeil
Some, Fatma F.
Lalloo, Umesh G.
Mwelase, Thando
Collier, Ann C.
Hughes, Michael D.
author_role author
author2 Harrison, Linda J.
La Rosa, Alberto M.
Cardoso, Sandra W.
Zheng, Lu
Ngongondo, McNeil
Some, Fatma F.
Lalloo, Umesh G.
Mwelase, Thando
Collier, Ann C.
Hughes, Michael D.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Torres, Thiago S.
Harrison, Linda J.
La Rosa, Alberto M.
Cardoso, Sandra W.
Zheng, Lu
Ngongondo, McNeil
Some, Fatma F.
Lalloo, Umesh G.
Mwelase, Thando
Collier, Ann C.
Hughes, Michael D.
dc.subject.en.en_US.fl_str_mv Quality of life
Raltegravir
HIV
Second-line therapy
Antiretroviral Therapy
Resource-limited settings
Randomized clinical trial
topic Quality of life
Raltegravir
HIV
Second-line therapy
Antiretroviral Therapy
Resource-limited settings
Randomized clinical trial
description Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2023-03-01T02:39:28Z
dc.date.available.fl_str_mv 2023-03-01T02:39:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv TORRES, Thiago S. et al. Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS, v. 32, n. 5, p. 583-593, 2018.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/57161
dc.identifier.issn.en_US.fl_str_mv 0269-9370
dc.identifier.doi.none.fl_str_mv 10.1097/QAD.0000000000001738
identifier_str_mv TORRES, Thiago S. et al. Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS, v. 32, n. 5, p. 583-593, 2018.
0269-9370
10.1097/QAD.0000000000001738
url https://www.arca.fiocruz.br/handle/icict/57161
dc.language.iso.fl_str_mv eng
language eng
dc.relation.isversionof.en_US.fl_str_mv https://www.arca.fiocruz.br/handle/icict/28806
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Wolters Kluwer Health
publisher.none.fl_str_mv Wolters Kluwer Health
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/57161/2/ve_Torres_Thiago_etal_INI_2018_ARTIGO%20FINAL.pdf
https://www.arca.fiocruz.br/bitstream/icict/57161/1/license.txt
bitstream.checksum.fl_str_mv b2e25459fdc195a8d3ce45704cdbc097
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008904665169920